Blog
LabGenius Therapeutics and LG Chem Enter a Research Collaboration, Option and License Agreement to Develop an AI/ML-Designed Tumour-Targeting Antibody
[#item_full_content]LONDON–(BUSINESS WIRE)– #AI–LabGenius Therapeutics (“LabGenius”), a drug discovery company combining machine learning (ML) and high-throughput experimentation…
[#item_full_content]
[#item_full_content]
Fed holds rates steady, pares down statement to remove cutting bias
[#item_full_content]The Federal Reserve on Wednesday released its interest rate decision.
[#item_full_content]
[#item_full_content]
[#item_full_content]
[#item_full_content]
[#item_full_content]
[#item_full_content]
[#item_full_content]
[#item_full_content]
[#item_full_content]
Jeffrey Gundlach says Fed’s Warsh is not going to be the ‘easy money’ chairman many hoped for
[#item_full_content]Gundlach said Warsh’s stance reduces the risk of overly accommodative monetary policy that could reignite inflation…
Fed holds rates steady, pares down statement to remove cutting bias
[#item_full_content]The Federal Reserve on Wednesday released its interest rate decision.
Chairman Warsh abstains from giving rate forecast as several members signal a hike in 2026
[#item_full_content]The median projection called for the federal funds rate to end 2026 at 3.8%, a quarter…